Bisker-Leib Vered
- SEC CIK
- 0001814093
No open-market purchases or sales filed in the past year.
Current role at each company
- CMPX Compass Therapeutics, Inc.CHIEF EXECUTIVE OFFICERas of Feb 9, 2024
- ADXS Ayala Pharmaceuticals, Inc.Directoras of Jan 23, 2023
- AYLA Old Ayala, IncDirectoras of Jan 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bisker-Leib Vered as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CMPX Compass Therapeutics, Inc.
CHIEF EXECUTIVE OFFICER2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2022 (view filing) | Nov 22-25 | 3 days | Bisker-Leib VeredChief Operating Officer | SSale | −24.5K | $4.23 | −$103.7K | −2.3%1.06M after | 3 lots |
| Nov 22, 2022 (view filing) | Nov 18-21 | 4 days | Bisker-Leib VeredChief Operating Officer | SSale | −22.3K | $4.36 | −$97.0K | −2.0%1.08M after | 2 lots |